Sign Up to like & get
recommendations!
0
Published in 2020 at "Gastric Cancer"
DOI: 10.1007/s10120-020-01139-4
Abstract: Despite the promising preclinical antitumor activity of MET-targeting therapies, most clinical trials have failed. We introduced a new concept of quantitation of stroma-induced hepatocyte growth factor (HGF) to assess the actual MET signalling activity in…
read more here.
Keywords:
gastric cancer;
ligand dependent;
met signalling;
signalling activation ... See more keywords